Effects of intracellular iron overload on cell death and identification of potent cell death inhibitors

Biochem Biophys Res Commun. 2018 Sep 3;503(1):297-303. doi: 10.1016/j.bbrc.2018.06.019. Epub 2018 Jun 11.

Abstract

Iron overload causes many diseases, while the underlying etiologies of these diseases are unclear. Cell death processes including apoptosis, necroptosis, cyclophilin D-(CypD)-dependent necrosis and a recently described additional form of regulated cell death called ferroptosis, are dependent on iron or iron-dependent reactive oxygen species (ROS). However, whether the accumulation of intracellular iron itself induces ferroptosis or other forms of cell death is largely elusive. In present study, we study the role of intracellular iron overload itself-induced cell death mechanisms by using ferric ammonium citrate (FAC) and a membrane-permeable Ferric 8-hydroxyquinoline complex (Fe-8HQ) respectively. We show that FAC-induced intracellular iron overload causes ferroptosis. We also identify 3-phosphoinositide-dependent kinase 1 (PDK1) inhibitor GSK2334470 as a potent ferroptosis inhibitor. Whereas, Fe-8HQ-induced intracellular iron overload causes unregulated necrosis, but partially activates PARP-1 dependent parthanatos. Interestingly, we identify many phenolic compounds as potent inhibitors of Fe-8HQ-induced cell death. In conclusion, intracellular iron overload-induced cell death form might be dependent on the intracellular iron accumulation rate, newly identified cell death inhibitors in our study that target ferroptosis and unregulated oxidative cell death represent potential therapeutic strategies against iron overload related diseases.

Keywords: Ferroptosis; Iron overload; Phenolic compounds; Unregulated necrosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3-Phosphoinositide-Dependent Protein Kinases / antagonists & inhibitors*
  • 3-Phosphoinositide-Dependent Protein Kinases / metabolism
  • Cell Death / drug effects*
  • Drug Discovery
  • Ferric Compounds / metabolism
  • HeLa Cells
  • Humans
  • Hydroxyquinolines / metabolism
  • Indazoles / pharmacology*
  • Iron / metabolism
  • Iron Overload / drug therapy*
  • Iron Overload / metabolism
  • Iron Overload / pathology*
  • Protein Kinase Inhibitors / pharmacology*
  • Pyrimidines / pharmacology*
  • Reactive Oxygen Species / metabolism

Substances

  • Ferric Compounds
  • GSK 2334470
  • Hydroxyquinolines
  • Indazoles
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Reactive Oxygen Species
  • ferric 8-hydroxyquinoline
  • Iron
  • 3-Phosphoinositide-Dependent Protein Kinases